menu
    • menu

    Find Lercanidipine manufacturers, exporters & distributors on PharmaCompass

    NEW Prospects: 4
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Synopsis

    Product SearchProduct Search

    Synopsis

    ACTIVE PHARMA INGREDIENTS

    27

    API Suppliers

    2

    USDMF

    0

    CEP/COS

    0

    JDMF

    6

    EU WC

    0

    KDMF

    0

    NDC API

    0

    VMF

    20

    Listed Suppliers

    4INTERMEDIATES

    REF. STANDARDS OR IMPURITIES

    0

    EDQM

    0

    USP

    0

    JP

    18

    Others

    FINISHED DOSAGE FORMULATIONS

    305

    FDF Dossiers

    0

    FDA Orange Book

    246

    Europe

    0

    Canada

    24

    Australia

    14

    South Africa

    21

    Listed Dossiers

    4PROSPECTS

    5DRUGS IN DEVELOPMENT

    FDF Dossiers

    DRUG PRODUCT COMPOSITIONS

    0RELATED EXCIPIENT COMPANIES

    0EXCIPIENTS BY APPLICATIONS

    PATENTS & EXCLUSIVITIES

    0

    US Patents

    0

    US Exclusivities

    0

    Health Canada Patents

    GLOBAL SALES INFORMATION

    US Medicaid

    NA

    Annual Reports

    NA

    Regulatory FDF Prices

    MARKET PLACE

    7

    API

    4

    FDF

    DIGITAL CONTENT

    0

    Data Compilation #PharmaFlow

    0

    Stock Recap #PipelineProspector

    0

    Weekly News Recap #Phispers

    0

    News #PharmaBuzz

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set
    Also known as: 100427-26-7, Lercanidipine [inn], Lercanil, Lercanidipine (inn), V7xtj4r0bh, Masnidipine
    Molecular Formula
    C36H41N3O6
    Molecular Weight
    611.7  g/mol
    InChI Key
    ZDXUKAKRHYTAKV-UHFFFAOYSA-N
    FDA UNII
    V7XTJ4R0BH
    Lercanidipine
    Lercanidipine is a calcium channel blocker of the dihydropyridine class. It is sold under various commercial names including Zanidip.
    1 2D Structure

    Lercanidipine

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    5-O-[1-[3,3-diphenylpropyl(methyl)amino]-2-methylpropan-2-yl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
    2.1.2 InChI
    InChI=1S/C36H41N3O6/c1-24-31(34(40)44-6)33(28-18-13-19-29(22-28)39(42)43)32(25(2)37-24)35(41)45-36(3,4)23-38(5)21-20-30(26-14-9-7-10-15-26)27-16-11-8-12-17-27/h7-19,22,30,33,37H,20-21,23H2,1-6H3
    2.1.3 InChI Key
    ZDXUKAKRHYTAKV-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CC1=C(C(C(=C(N1)C)C(=O)OC(C)(C)CN(C)CCC(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC(=CC=C4)[N+](=O)[O-])C(=O)OC
    2.2 Other Identifiers
    2.2.1 UNII
    V7XTJ4R0BH
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Lercadip

    2. Lercanidipine Hydrochloride

    3. Lerdip

    4. Methyl-1,1-dimethyl-2-(n-(3,3-diphenylpropyl)-n-methylamino)ethyl-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate

    5. Rec 15-2375

    6. Rec-15-2375

    7. Zanidip

    2.3.2 Depositor-Supplied Synonyms

    1. 100427-26-7

    2. Lercanidipine [inn]

    3. Lercanil

    4. Lercanidipine (inn)

    5. V7xtj4r0bh

    6. Masnidipine

    7. 3,5-pyridinedicarboxylic Acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 3-[2-[(3,3-diphenylpropyl)methylamino]-1,1-dimethylethyl] 5-methyl Ester

    8. 5-o-[1-[3,3-diphenylpropyl(methyl)amino]-2-methylpropan-2-yl] 3-o-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate

    9. 1-[(3,3-diphenylpropyl)(methyl)amino]-2-methylpropan-2-yl Methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate

    10. 3-(1-((3,3-diphenylpropyl)(methyl)amino)-2-methylpropan-2-yl) 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate

    11. 3-{1-[(3,3-diphenylpropyl)(methyl)amino]-2-methylpropan-2-yl} 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate

    12. Lercanil (tn)

    13. Ncgc00167492-01

    14. Unii-v7xtj4r0bh

    15. Lercanidipine [inn:ban]

    16. Lercanadipine

    17. 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic Acid O5-[1-[3,3-diphenylpropyl(methyl)amino]-2-methylpropan-2-yl] Ester O3-methyl Ester

    18. Lercanidipine [mi]

    19. Schembl25268

    20. Lercanidipine [who-dd]

    21. Chembl250270

    22. Schembl6846222

    23. Dtxsid2048327

    24. Chebi:135930

    25. Hms3604g05

    26. Bcp21318

    27. Hy-b0612

    28. Bbl029074

    29. S5861

    30. Stk639861

    31. Akos005571238

    32. Db00528

    33. Sdccgsbi-0633690.p001

    34. Ncgc00167492-02

    35. Ncgc00167492-11

    36. (+-)-2-((3,3-diphenylpropyl)methylamino)-1,1-dimethylethyl Methyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate

    37. Ac-15409

    38. As-75252

    39. Ft-0631006

    40. C13971

    41. D08111

    42. 427l267

    43. A800200

    44. A929939

    45. Q410492

    46. Sr-01000884000

    47. Sr-01000884000-1

    48. [2-oxo-3-(3-trifluoromethyl-phenoxy)-propyl]-phosphonic

    49. 2-((3,3-diphenylpropyl)methylamino)-1,1-dimethylethyl Methyl (4rs)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate

    50. 3,5-pyridinedicarboxylic Acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-((3,3-diphenylpropyl)methylamino)-1,1-dimethylethyl Methyl Ester

    51. 3,5-pyridinedicarboxylic Acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-(3,3-diphenylpropyl)methylamino)-1,1-dimethylethyl Methyl Ester

    52. O5-[1-[3,3-diphenylpropyl(methyl)amino]-2-methyl-propan-2-yl] O3-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate

    2.4 Create Date
    2005-06-24
    3 Chemical and Physical Properties
    Molecular Weight 611.7 g/mol
    Molecular Formula C36H41N3O6
    XLogP36.9
    Hydrogen Bond Donor Count1
    Hydrogen Bond Acceptor Count8
    Rotatable Bond Count13
    Exact Mass611.29953604 g/mol
    Monoisotopic Mass611.29953604 g/mol
    Topological Polar Surface Area114 Ų
    Heavy Atom Count45
    Formal Charge0
    Complexity1090
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count1
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Indication

    For the treatment of Hypertension, management of angina pectoris and Raynaud's syndrome

    5 Pharmacology and Biochemistry
    5.1 Pharmacology

    Lercanidipine, a dihydropyridine calcium-channel blocker, is used alone or with an angiotensin-converting enzyme inhibitor, to treat hypertension, chronic stable angina pectoris, and Prinzmetal's variant angina. Lercanidipine is similar to other peripheral vasodilators. Lercanidipine inhibits the influx of extra cellular calcium across the myocardial and vascular smooth muscle cell membranes possibly by deforming the channel, inhibiting ion-control gating mechanisms, and/or interfering with the release of calcium from the sarcoplasmic reticulum. The decrease in intracellular calcium inhibits the contractile processes of the myocardial smooth muscle cells, causing dilation of the coronary and systemic arteries, increased oxygen delivery to the myocardial tissue, decreased total peripheral resistance, decreased systemic blood pressure, and decreased afterload.

    5.2 MeSH Pharmacological Classification

    Antihypertensive Agents

    Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)

    Calcium Channel Blockers

    A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)

    5.3 ATC Code

    C08CA13

    S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355

    C - Cardiovascular system

    C08 - Calcium channel blockers

    C08C - Selective calcium channel blockers with mainly vascular effects

    C08CA - Dihydropyridine derivatives

    C08CA13 - Lercanidipine

    5.4 Mechanism of Action

    By deforming the channel, inhibiting ion-control gating mechanisms, and/or interfering with the release of calcium from the sarcoplasmic reticulum, Lercanidipine inhibits the influx of extracellular calcium across the myocardial and vascular smooth muscle cell membranes The decrease in intracellular calcium inhibits the contractile processes of the myocardial smooth muscle cells, causing dilation of the coronary and systemic arteries, increased oxygen delivery to the myocardial tissue, decreased total peripheral resistance, decreased systemic blood pressure, and decreased afterload.

    Global Sales Information

    Do you need Business Intel? Ask us

    Market Place

    Do you need sourcing support? Ask us

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Looking for 100427-26-7 / Lercanidipine API manufacturers, exporters & distributors?

    Lercanidipine manufacturers, exporters & distributors 1

    63

    PharmaCompass offers a list of Lercanidipine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Lercanidipine manufacturer or Lercanidipine supplier for your needs.

    Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Lercanidipine manufacturer or Lercanidipine supplier.

    API | Excipient name

    Lercanidipine

    Synonyms

    100427-26-7, Lercanidipine [inn], Lercanil, Lercanidipine (inn), V7xtj4r0bh, Masnidipine

    Cas Number

    100427-26-7

    Unique Ingredient Identifier (UNII)

    V7XTJ4R0BH

    About Lercanidipine

    Lercanidipine is a calcium channel blocker of the dihydropyridine class. It is sold under various commercial names including Zanidip.

    Lercanil (TN) Manufacturers

    A Lercanil (TN) manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lercanil (TN), including repackagers and relabelers. The FDA regulates Lercanil (TN) manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lercanil (TN) API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

    click here to find a list of Lercanil (TN) manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

    Lercanil (TN) Suppliers

    A Lercanil (TN) supplier is an individual or a company that provides Lercanil (TN) active pharmaceutical ingredient (API) or Lercanil (TN) finished formulations upon request. The Lercanil (TN) suppliers may include Lercanil (TN) API manufacturers, exporters, distributors and traders.

    click here to find a list of Lercanil (TN) suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

    Lercanil (TN) USDMF

    A Lercanil (TN) DMF (Drug Master File) is a document detailing the whole manufacturing process of Lercanil (TN) active pharmaceutical ingredient (API) in detail. Different forms of Lercanil (TN) DMFs exist exist since differing nations have different regulations, such as Lercanil (TN) USDMF, ASMF (EDMF), JDMF, CDMF, etc.

    A Lercanil (TN) DMF submitted to regulatory agencies in the US is known as a USDMF. Lercanil (TN) USDMF includes data on Lercanil (TN)'s chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Lercanil (TN) USDMF is kept confidential to protect the manufacturer’s intellectual property.

    click here to find a list of Lercanil (TN) suppliers with USDMF on PharmaCompass.

    Lercanil (TN) WC

    A Lercanil (TN) written confirmation (Lercanil (TN) WC) is an official document issued by a regulatory agency to a Lercanil (TN) manufacturer, verifying that the manufacturing facility of a Lercanil (TN) active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Lercanil (TN) APIs or Lercanil (TN) finished pharmaceutical products to another nation, regulatory agencies frequently require a Lercanil (TN) WC (written confirmation) as part of the regulatory process.

    click here to find a list of Lercanil (TN) suppliers with Written Confirmation (WC) on PharmaCompass.

    Lercanil (TN) GMP

    Lercanil (TN) Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

    GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

    PharmaCompass offers a list of Lercanil (TN) GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Lercanil (TN) GMP manufacturer or Lercanil (TN) GMP API supplier for your needs.

    Lercanil (TN) CoA

    A Lercanil (TN) CoA (Certificate of Analysis) is a formal document that attests to Lercanil (TN)'s compliance with Lercanil (TN) specifications and serves as a tool for batch-level quality control.

    Lercanil (TN) CoA mostly includes findings from lab analyses of a specific batch. For each Lercanil (TN) CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

    Lercanil (TN) may be tested according to a variety of international standards, such as European Pharmacopoeia (Lercanil (TN) EP), Lercanil (TN) JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lercanil (TN) USP).

    Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
    For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search